Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Virus and Host

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1604259

This article is part of the Research TopicGenetic and Molecular Markers in Viral InfectionsView all 4 articles

TLR3 rs3775291C/T polymorphism is associated with elevated IFN-α level in asymptomatic HTLV-1 infection

Provisionally accepted
  • 1Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil
  • 2Laboratory of Cellular and Molecular Biology, Tropical Medicine Center, Federal University of Pará, Belém, Pará, Brazil

The final, formatted version of the article will be published soon.

Introduction: Alterations in the immune response may influence the development of HTLV-1-associated diseases. TLR3 detects viral nucleic acids, including HTLV-1, and triggers the production of IFN-I and other cytokines. Genetic variations in TLR3 may alter the antiviral and inflammatory responses and contribute to the progression of HTLV-1 infection. The present study investigated the association of polymorphisms in the TLR3 gene (rs5743305T/A and rs3775291C/T) with HTLV-1 infection status and their relationship with infection-associated diseases, receptor expression levels, proviral load, and inflammatory and antiviral cytokines.Methods: Blood samples were collected from 179 individuals with HTLV-1 infection (82 with inflammatory diseases and 97 asymptomatic individuals) and 179 controls. Genotyping of polymorphisms, analysis of TLR3 gene expression, and quantification of proviral load were performed by real-time PCR, and cytokine levels were measured by enzyme-linked immunosorbent assay (ELISA). Results: The polymorphisms showed no correlation with susceptibility to HTLV-1 infection, or the occurrence of disease symptoms linked to the infection. The presence of disease symptoms was associated with higher TNF-α levels and proviral load. TLR3 rs5743305T/A polymorphism was not associated with variations in TLR3 and IFN-α levels. For the TLR3 rs3775291C/T polymorphism, asymptomatic individuals carrying the TT polymorphic genotype presented significantly higher IFN-α levels and lower proviral load. The profile of asymptomatic individuals carrying the polymorphic genotypes for TLR3 rs3775291C/T was characterized by higher levels of TLR3 and IFN-α and lower levels of proviral load, TNF-α and IL-6 compared to those with the wild-type genotype.Conclusion: Although polymorphisms in the TLR3 gene have not been associated with the presence of symptoms of HTLV-1-related inflammatory diseases, the TLR3 rs3775291C/T polymorphism appears to contribute to a better evolution of the HTLV-1 infection status and inflammatory process among asymptomatic individuals.

Keywords: HTLV-I infection, Inflammatory diseases, Toll-Like Receptor 3, Polymorphism genetic, Cytokines

Received: 01 Apr 2025; Accepted: 03 Jul 2025.

Copyright: © 2025 Ferreira, Brito, Mendes Santana, Oliveira, Lima, Amoras, Da Costa, Sousa, Lima, Ishak, Cayres-Vallinoto, Vallinoto and Queiroz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Maria Alice Freitas Queiroz, Laboratory of Virology, Institute of Biological Sciences, Federal University of Pará, Belém, 66075-110, Pará, Brazil

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.